 |
|
Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis
A Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study
Celia Oreja-Guevara, MD;
Marco Rovaris, MD;
Giuseppe Iannucci, MD;
Paola Valsasina, PhD;
Domenico Caputo, MD;
Rosella Cavarretta, MD;
Maria Pia Sormani, PhD;
Pasquale Ferrante, MD;
Giancarlo Comi, MD;
Massimo Filippi, MD
Arch Neurol. 2005;62:578-584.
Background Diffusion tensor magnetic resonance imaging (DT MRI) has the potential to provide in vivo information about tissue microstructure. In multiple sclerosis (MS), DT MRI has disclosed the presence of occult structural damage in the normal-appearing brain tissues.
Objective To investigate whether DT MRI is sensitive to longitudinal changes of brain damage that may occur beyond the resolution of T2-weighted images in patients with relapsing-remitting MS.
Design Twenty-six untreated patients with relapsing-remitting MS were followed up for 18 months. Dual-echo, DT and postcontrast T1-weighted MRIs of the brain were obtained at baseline and then every 3 months. Mean diffusivity ( ) histograms of normal-appearing gray (GM) and white matter were produced. Total T2-hyperintense and T1-hypointense lesion volumes; normalized whole brain tissue, GM, and white matter volumes; percentage brain volume change between the study entry and exit images; average lesion ; and fractional anisotropy were also calculated.
Results During the study period, a significant decrease of normalized whole brain tissue, average lesion fractional anisotropy and normal-appearing GM histogram peak height, and a significant increase of average normal-appearing GM and T2-hyperintense lesion volumes were observed. Changes of normal-appearing GM diffusivity were independent of the concomitant changes of normalized whole brain tissue and GM volumes.
Conclusions The DT MRI findings show progressive microstructural changes in the normal-appearing GM of patients with untreated relapsing-remitting MS. Such changes do not reflect a concomitant development of brain atrophy and confirm the importance of GM pathology in MS.
Author Affiliations: Neuroimaging Unit (Drs Oreja-Guevara, Rovaris, Iannucci, Valsasina, Sormani, and Filippi) and Department of Neurology (Dr Comi), Scientific Institute and University H San Raffaele, and Department of Neurology, Fondazione Don Gnocchi (Drs Caputo, Cavarretta, and Ferrante), Milan, Italy.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
Mesaros et al.
Neurology 2008;70:1107-1112.
ABSTRACT
| FULL TEXT
Diffusion-Tensor MR Imaging of Cortical Lesions in Multiple Sclerosis: Initial Findings
Poonawalla et al.
Radiology 2008;246:880-886.
ABSTRACT
| FULL TEXT
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
Agosta et al.
Brain 2007;130:2211-2219.
ABSTRACT
| FULL TEXT
Diffusion Anisotropy Measurement of Brain White Matter Is Affected by Voxel Size: Underestimation Occurs in Areas with Crossing Fibers
Oouchi et al.
Am. J. Neuroradiol. 2007;28:1102-1106.
ABSTRACT
| FULL TEXT
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Agosta et al.
Brain 2006;129:2620-2627.
ABSTRACT
| FULL TEXT
Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study
Charil et al.
Mult Scler 2006;12:662-665.
ABSTRACT
Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Oreja-Guevara et al.
Arch Neurol 2006;63:736-740.
ABSTRACT
| FULL TEXT
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Frohman et al.
Arch Neurol 2006;63:614-619.
FULL TEXT
Diffusion MRI in multiple sclerosis
Rovaris et al.
Neurology 2005;65:1526-1532.
ABSTRACT
| FULL TEXT
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution
Rovaris et al.
Neurology 2005;65:1626-1630.
ABSTRACT
| FULL TEXT
Evidence for progressive gray matter loss in patients with relapsing-remitting MS
Valsasina et al.
Neurology 2005;65:1126-1128.
ABSTRACT
| FULL TEXT
|
